Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients

Allsop, 2014, Changes in cigarette and alcohol use during cannabis abstinence, Drug and Alcohol Dependence, 138, 54, 10.1016/j.drugalcdep.2014.01.022

Bachhuber, 2014, Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999–2010, JAMA Internal Medicine, 4, 1

Belle-Isle, 2014, Barriers to access for Canadians who use cannabis for therapeutic purposes, International Journal of Drug Policy, 25, 691, 10.1016/j.drugpo.2014.02.009

Blessing, 2015, Cannabidiol as a potential treatment for anxiety disorders, Neurotherapeutics, 12, 825, 10.1007/s13311-015-0387-1

Bonn-Miller, 2014, Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users, The American Journal of Drug and Alcohol Abuse, 40, 23, 10.3109/00952990.2013.821477

Bradford, 2016, Medical marijuana laws reduce prescription medication use in medicare part D, Health Affairs, 35, 1230, 10.1377/hlthaff.2015.1661

Brown, 2011, Medication adherence: WHO cares?, Mayo Clinic Proceedings, 86, 304, 10.4065/mcp.2010.0575

Carter, 2004, Medicinal cannabis: Rational guidelines for dosing, IDrugs: The Investigational Drugs Journal, 7, 464

Clark, 2013, The state of play, International Journal of Play, 1

Eysenbach, 2004, Improving the quality of web surveys: The checklist for reporting results of internet e-surveys (CHERRIES), Journal of Medical Internet Research, 6, e34+, 10.2196/jmir.6.3.e34

Fischer, 2015, Medical marijuana programs—Why might they matter for public health and why should we better understand their impacts?, PMEDR, 2, 53

Fischer, 2008, Non-medical use of prescription opioids and public health in Canada: An urgent call for research and interventions development, Canadian Journal of Public Health, 99, 182, 10.1007/BF03405469

Hager, 2016

Hazekamp, 2013, The medicinal use of cannabis and cannabinoids—An international cross-sectional survey on administration forms, Journal of Psychoactive Drugs, 45, 199, 10.1080/02791072.2013.805976

Ingersoll, 2008, The impact of medication regimen factors on adherence to chronic treatment: A review of literature, Journal of Behavioral Medicine, 31, 213, 10.1007/s10865-007-9147-y

Linge, 2015, Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: Role of 5-HT1A receptors, Neuropharmacology, 103, 16, 10.1016/j.neuropharm.2015.12.017

Lucas, 2012, Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain, Journal of Psychoactive Drugs, 44, 125, 10.1080/02791072.2012.684624

Lucas, 2012, It can’t hurt to ask: A patient-centered quality of service assessment of health Canada’s medical cannabis policy and program, Harm Reduction Journal, 9, 2, 10.1186/1477-7517-9-2

Lucas, 2013, Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients, Addiction Research & Theory, 21, 435, 10.3109/16066359.2012.733465

Lucas, 2016, Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors, Drug and Alcohol Review, 35, 326, 10.1111/dar.12323

Office of Medical Cannabis, 2016, 2016

Ogborne, 2000, Who is using cannabis as a medicine and why: An exploratory study, Journal of Psychoactive Drugs, 32, 435, 10.1080/02791072.2000.10400245

Reiman, 2009, Cannabis as a substitute for alcohol and other drugs, Harm Reduction Journal, 6, 35, 10.1186/1477-7517-6-35

Sawler, 2015, The genetic structure of marijuana and hemp, PLoS One, 10, e0133292, 10.1371/journal.pone.0133292

Sylvestre, 2006, Cannabis use improves retention and virological outcomes in patients treated for hepatitis C, European Journal of Gastroenterology & Hepatology, 18, 1057, 10.1097/01.meg.0000216934.22114.51

Walsh, 2013, Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use, International Journal of Drug Policy, 24, 511, 10.1016/j.drugpo.2013.08.010

Walsh, 2016, Medical cannabis and mental health: A guided systematic review, Clinical Psychology Review, 15

Ware, 2010, Smoked cannabis for chronic neuropathic pain: A randomized controlled trial, Cmaj, 182, 1, 10.1503/cmaj.091414

Ware, 2015, Cannabis for the management of pain: Assessment of safety study (COMPASS), The Journal of Pain, 1233, 10.1016/j.jpain.2015.07.014